146 related articles for article (PubMed ID: 7188941)
41. Antitumor activity of cis-dihalogenobis(1-phenyl-1,3-butanedionato) titanium(IV) compounds against Walker 256 carcinosarcoma. A new class of antineoplastic agents.
Keller HJ; Keppler B; Schmähl D
Arzneimittelforschung; 1982; 32(8):806-7. PubMed ID: 6890355
[TBL] [Abstract][Full Text] [Related]
42. Antitumor effect of palmitoleic acid on Ehrlich ascites tumor.
Ito H; Kasama K; Naruse S; Shimura K
Cancer Lett; 1982; 17(2):197-203. PubMed ID: 7165872
[TBL] [Abstract][Full Text] [Related]
43. Importance of T-cells and macrophages in the antitumor activity of carboxyethylgermanium sesquioxide (Ge-132).
Suzuki F; Brutkiewicz RR; Pollard RB
Anticancer Res; 1985; 5(5):479-83. PubMed ID: 3877491
[TBL] [Abstract][Full Text] [Related]
44. Organometallic anticancer agents: the effect of the central metal and halide ligands on the interaction of metallocene dihalides Cp2MX2 with nucleic acid constituents.
Murray JH; Harding MM
J Med Chem; 1994 Jun; 37(13):1936-41. PubMed ID: 8027975
[TBL] [Abstract][Full Text] [Related]
45. Antitumor activity of cis-dihalogenobis(1-phenyl-1,3-butanedionato)titanium (IV) compounds. A new class of antineoplastic agents.
Keller HJ; Keppler B; Schmähl D
J Cancer Res Clin Oncol; 1983; 105(1):109-10. PubMed ID: 6682104
[No Abstract] [Full Text] [Related]
46. Antitumor activity of Titanocene Y against freshly explanted human breast tumor cells and in xenografted MCF-7 tumors in mice.
Beckhove P; Oberschmidt O; Hanauske AR; Pampillón C; Schirrmacher V; Sweeney NJ; Strohfeldt K; Tacke M
Anticancer Drugs; 2007 Mar; 18(3):311-5. PubMed ID: 17264764
[TBL] [Abstract][Full Text] [Related]
47. Pattern of toxicity by titanocene dichloride in mice: hematologic parameters.
Köpf-Maier P; Gerlach S
Anticancer Res; 1986; 6(2):235-40. PubMed ID: 3707061
[TBL] [Abstract][Full Text] [Related]
48. Cytologic observations on the effects of metallocene dichlorides on human fibroblasts cultivated in vitro.
Köpf-Maier P; Hermann G
Virchows Arch B Cell Pathol Incl Mol Pathol; 1984; 47(2):107-22. PubMed ID: 6151291
[TBL] [Abstract][Full Text] [Related]
49. Antitumor organometallics. II. Inhibitory effects of two diphenyl-antimony (III) dithiophosphorus derivatives on in vitro and in vivo Ehrlich ascites tumor.
Socaciu C; Bara A; Silvestru C; Haiduc I
In Vivo; 1991; 5(4):425-8. PubMed ID: 1667268
[TBL] [Abstract][Full Text] [Related]
50. [Antitumor mechanisms of carboxyethyl-germanium sesquioxide (Ge-132) in mice bearing Ehrlich ascites tumors].
Suzuki F
Gan To Kagaku Ryoho; 1987 Jan; 14(1):127-34. PubMed ID: 3800401
[TBL] [Abstract][Full Text] [Related]
51. Synthesis and antitumor evaluation of selected 5,6-disubstituted 1(2)H-indazole-4,7-diones.
Conway GA; Loeffler LJ; Hall IH
J Med Chem; 1983 Jun; 26(6):876-84. PubMed ID: 6854591
[TBL] [Abstract][Full Text] [Related]
52. Synergism between propolis and hyperthermal intraperitoneal chemotherapy with cisplatin on ehrlich ascites tumor in mice.
Oršolić N; Car N; Lisičić D; Benković V; Knežević AH; Dikić D; Petrik J
J Pharm Sci; 2013 Dec; 102(12):4395-405. PubMed ID: 24136132
[TBL] [Abstract][Full Text] [Related]
53. Tumor inhibition by titanocene complexes: influence upon two xenografted human lung carcinomas.
Köpf-Maier P
J Cancer Res Clin Oncol; 1987; 113(4):342-8. PubMed ID: 3036884
[TBL] [Abstract][Full Text] [Related]
54. Cytocidal and toxic effect of various cytostatic drugs on three ascites tumors of the mouse.
Schäfer E; Maurer-Schultze B
J Cancer Res Clin Oncol; 1987; 113(3):216-22. PubMed ID: 3584212
[TBL] [Abstract][Full Text] [Related]
55. Effect of pentazocine on Ehrlich ascites tumor cells.
Kigoshi S
Jpn J Pharmacol; 1981 Oct; 31(5):781-5. PubMed ID: 7311171
[TBL] [Abstract][Full Text] [Related]
56. [Effect of nitidine chloride on the life cycle of Ehrlich ascites carcinoma cells in mice (author's transl)].
Fan YJ; Zhou J; Li M
Zhongguo Yao Li Xue Bao; 1981 Mar; 2(1):46-9. PubMed ID: 6461202
[No Abstract] [Full Text] [Related]
57. Influence of N-(o-methoxyphenyl)-maleimide on 5-fluorouracil cytotoxicity in Ehrlich (ascites) carcinoma.
Ambaye RY; Indap MA
Cancer Lett; 1991 Apr; 57(1):21-6. PubMed ID: 1902758
[TBL] [Abstract][Full Text] [Related]
58. Evaluation of anti-tumor efficacy of injectable Centchroman in mice bearing Ehrlich ascites carcinoma.
Shenoy BD; Udupa N; Kamath R; Devi PU
Indian J Physiol Pharmacol; 1999 Apr; 43(2):259-62. PubMed ID: 10365323
[TBL] [Abstract][Full Text] [Related]
59. [The difference of drug sensitivity of tumor cells on N-ethyloxycarbonylaminomethyl-L-isoleucine (A-145 (author's transl)].
Tomioka H; Fukushima K; Toyoshima S
Nihon Yakurigaku Zasshi; 1979 Jan; 75(1):53-9. PubMed ID: 437584
[TBL] [Abstract][Full Text] [Related]
60. Preliminary evaluation of in vitro cytotoxicity and in vivo antitumor activity of Premna herbacea Roxb. in Ehrlich ascites carcinoma model and Dalton's lymphoma ascites model.
Dhamija I; Kumar N; Manjula SN; Parihar V; Setty MM; Pai KS
Exp Toxicol Pathol; 2013 Mar; 65(3):235-42. PubMed ID: 21920724
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
